In-Vitro Diagnostic Substance Manufacturing contractors at the Department of Veterans Affairs
- Latest 12 months
- $106.0M
- Net obligations · Down $11.9M vs. $117.9M preceding
- Prime contractors
- 77
- With positive obligations in the latest 12 months
Market snapshot for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs
Federal records show $772.4M in net obligations across 3,794 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Jul 27, 2026. This market accounts for 0.24% of $316.4B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 10.1% from $117.9M to $106.0M. 11 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $284.9M | 1,711 | Complete |
| FY2023 | $201.9M | 1,647 | Complete |
| FY2024 | $77.3M | 1,831 | Complete |
| FY2025 | $109.6M | 1,626 | Complete |
| FY2026 | $98.7M | 1,395 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $772.4M
- 3,794 awards · 171 prime contractors
- Latest 12-month movement
- −10.1%
- $106.0M vs. $117.9M
- Leading eight prime share
- 77.0%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.24% of $316.4B in agency-wide net obligations.
- Set-aside share when reported
- 17.0% of 1,488 awards with reported set-aside status.
- Set-aside reporting
- 253 set aside · 1,235 no set-aside · 2,306 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Competitive shifts
CEPHEID had the largest decline in reported obligations
ROCHE DIAGNOSTICS CORPORATION gained the most market share
ASE DIRECT, INC. had no reported activity in the latest 12 months
Market structure
Top-five contractor share increased
Buyer demand
Reported obligations through 644-PHOENIX (00644) increased
View 1 additional material change
Buyer demand
Reported obligations through 664-SAN DIEGO HEALTHCARE SYS(00664) decreased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
6.0% of positive obligations were attributed to 691-VA GREATER LA HLTHCR SYS(00691). That represents $6.7M, down $1.2M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- 691-VA GREATER LA HLTHCR SYS(00691)6.0% · $6.7M · down $1.2M
- 261-NETWORK CONTRACT OFFICE 21 (36C261)5.9% · $6.6M · up $2.4M
- 644-PHOENIX (00644)5.7% · $6.4M · up $4.2M
- 248-NETWORK CONTRACT OFFICE 8 (36C248)5.6% · $6.3M · up $1.7M
- 600-VA LONG BEACH HLTCAR SYS(00600)4.4% · $5.0M · up $1.3M
- All other reported offices72.4% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
691-VA GREATER LA HLTHCR SYS(00691)
#1Rank unchangedLatest 12 months
$6.7M
6.0% of positive obligations
Versus preceding 12 months
−$1.2M
20 active prime contractors · 39 awards
View office comparison and evidence
Reported obligations decreased 15.2% from $7.9M to $6.7M. The office’s share of positive obligations moved from 6.4% to 6.0%, a change of −0.4 percentage points.
The latest period contains 55 actions across 39 awards and 7 newly active prime contractors. The preceding period contained 16 active prime contractors and 28 awards.
Reported funding office
261-NETWORK CONTRACT OFFICE 21 (36C261)
#2Up 3 from #5Latest 12 months
$6.6M
5.9% of positive obligations
Versus preceding 12 months
+$2.4M
5 active prime contractors · 25 awards
View office comparison and evidence
Reported obligations increased 57.3% from $4.2M to $6.6M. The office’s share of positive obligations moved from 3.4% to 5.9%, a change of +2.5 percentage points.
The latest period contains 32 actions across 25 awards and 1 newly active prime contractor. The preceding period contained 9 active prime contractors and 39 awards.
Reported funding office
644-PHOENIX (00644)
#3Up 13 from #16Latest 12 months
$6.4M
5.7% of positive obligations
Versus preceding 12 months
+$4.2M
5 active prime contractors · 23 awards
View office comparison and evidence
Reported obligations increased 190.2% from $2.2M to $6.4M. The office’s share of positive obligations moved from 1.8% to 5.7%, a change of +3.9 percentage points.
The latest period contains 40 actions across 23 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 8 awards.
Reported funding office
248-NETWORK CONTRACT OFFICE 8 (36C248)
#4Rank unchangedLatest 12 months
$6.3M
5.6% of positive obligations
Versus preceding 12 months
+$1.7M
4 active prime contractors · 12 awards
View office comparison and evidence
Reported obligations increased 35.9% from $4.7M to $6.3M. The office’s share of positive obligations moved from 3.8% to 5.6%, a change of +1.9 percentage points.
The latest period contains 16 actions across 12 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 15 awards.
Reported funding office
600-VA LONG BEACH HLTCAR SYS(00600)
#5Up 1 from #6Latest 12 months
$5.0M
4.4% of positive obligations
Versus preceding 12 months
+$1.3M
6 active prime contractors · 10 awards
View office comparison and evidence
Reported obligations increased 36.0% from $3.7M to $5.0M. The office’s share of positive obligations moved from 3.0% to 4.4%, a change of +1.5 percentage points.
The latest period contains 13 actions across 10 awards and 1 newly active prime contractor. The preceding period contained 8 active prime contractors and 12 awards.
Reported funding office
674-TEMPLE (00674)
#6New to the positive-obligation rankingLatest 12 months
$4.5M
4.0% of positive obligations
Versus preceding 12 months
+$5.3M
11 active prime contractors · 16 awards
View office comparison and evidence
Reported obligations moved from $743K in net deobligations to $4.5M in net obligations. The office’s share of positive obligations moved from 0% to 4.0%, a change of +4.0 percentage points.
The latest period contains 34 actions across 16 awards and 2 newly active prime contractors. The preceding period contained 11 active prime contractors and 17 awards.
Leading award-level changes
- ROCHE DIAGNOSTICS CORPORATION · PIID 36C25722C0025+$1.7M: −$1.0M → $677K
- CEPHEID · PIID 36C25726N0164+$1.6M: $0 → $1.6M
Reported funding office
241-NETWORK CONTRACT OFFICE 01 (36C241)
#7Rank unchangedLatest 12 months
$4.4M
3.9% of positive obligations
Versus preceding 12 months
+$817K
16 active prime contractors · 33 awards
View office comparison and evidence
Reported obligations increased 22.8% from $3.6M to $4.4M. The office’s share of positive obligations moved from 2.9% to 3.9%, a change of +1.0 percentage points.
The latest period contains 46 actions across 33 awards and 6 newly active prime contractors. The preceding period contained 14 active prime contractors and 29 awards.
Reported funding office
549-DALLAS (00549)
#8Up 11 from #19Latest 12 months
$3.3M
2.9% of positive obligations
Versus preceding 12 months
+$1.2M
18 active prime contractors · 30 awards
View office comparison and evidence
Reported obligations increased 55.5% from $2.1M to $3.3M. The office’s share of positive obligations moved from 1.7% to 2.9%, a change of +1.2 percentage points.
The latest period contains 39 actions across 30 awards and 3 newly active prime contractors. The preceding period contained 15 active prime contractors and 25 awards.
Reported funding office
664-SAN DIEGO HEALTHCARE SYS(00664)
#9Down 6 from #3Latest 12 months
$2.9M
2.6% of positive obligations
Versus preceding 12 months
−$2.5M
10 active prime contractors · 16 awards
View office comparison and evidence
Reported obligations decreased 46.5% from $5.4M to $2.9M. The office’s share of positive obligations moved from 4.4% to 2.6%, a change of −1.8 percentage points.
The latest period contains 24 actions across 16 awards and 3 newly active prime contractors. The preceding period contained 10 active prime contractors and 14 awards.
Reported funding office
675-ORLANDO (00675)(36C675)
#10Down 2 from #8Latest 12 months
$2.7M
2.4% of positive obligations
Versus preceding 12 months
−$508K
2 active prime contractors · 4 awards
View office comparison and evidence
Reported obligations decreased 16.0% from $3.2M to $2.7M. The office’s share of positive obligations moved from 2.6% to 2.4%, a change of −0.2 percentage points.
The latest period contains 4 actions across 4 awards. The preceding period contained 2 active prime contractors and 4 awards.
Reported funding office
VA COMP LEVENWORTH (00760)
#72Down 63 from #9Latest 12 months
$247K
0.22% of positive obligations
Versus preceding 12 months
−$2.9M
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations decreased 92.2% from $3.2M to $247K. The office’s share of positive obligations moved from 2.6% to 0.22%, a change of −2.3 percentage points.
The latest period contains 1 action across 1 award. The preceding period contained 5 active prime contractors and 9 awards.
Reported funding office
673-TAMPA(00673)(36C673)
No positive-obligation rankLatest 12 months
−$45K
0% of positive obligations
Versus preceding 12 months
+$1.7M
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations narrowed from $1.7M to $45K in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 1 action across 1 award. The preceding period contained 6 active prime contractors and 23 awards.
Reported funding office
DEPT OF VETERANS AFFAIRS
No positive-obligation rankLatest 12 months
−$182K
0% of positive obligations
Versus preceding 12 months
−$2.4M
5 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations moved from $2.2M in net obligations to $182K in net deobligations. The office’s share of positive obligations moved from 1.8% to 0%, a change of −1.8 percentage points.
The latest period contains 8 actions across 7 awards. The preceding period contained 5 active prime contractors and 10 awards.
Reported funding office
589 KAN WESTERN ORBIT
No positive-obligation rankLatest 12 months
−$2.0M
0% of positive obligations
Versus preceding 12 months
−$9.8M
13 active prime contractors · 29 awards
View office comparison and evidence
Reported obligations moved from $7.8M in net obligations to $2.0M in net deobligations. The office’s share of positive obligations moved from 6.3% to 0%, a change of −6.3 percentage points.
The latest period contains 51 actions across 29 awards and 1 newly active prime contractor. The preceding period contained 18 active prime contractors and 40 awards.
Leading award-level changes
- CEPHEID · PIID 36C25524N0348−$4.5M: $3.1M → −$1.4M
- CEPHEID · PIID 36C25525N0329−$2.8M: $2.9M → $54K
Reported funding office
534-CHARLESTON (00534)(36C534)
No positive-obligation rankLatest 12 months
−$2.0M
0% of positive obligations
Versus preceding 12 months
−$3.3M
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations moved from $1.3M in net obligations to $2.0M in net deobligations. The office’s share of positive obligations moved from 1.0% to 0%, a change of −1.0 percentage points.
The latest period contains 4 actions across 1 award. The preceding period contained 1 active prime contractor and 1 award.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs.
During Jul 28, 2025–Jul 27, 2026, this market recorded $136.0M in positive net award obligations across 713 awards. The leading reported procedure, Simplified Acquisition, accounted for 39.6% of that positive-obligation base. Awards with a reported parent IDV accounted for 76.7%.
- Leading award type
- 45.3%
- Delivery Order
- Leading reported procedure
- 39.6%
- Simplified Acquisition
- Reported parent IDV
- 76.7%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 332 of 713 awards reported offers
Same-NAICS comparison
Compared with the NAICS 325413 peer median, parent-IDV obligation share is 18.2 percentage points higher, reported full-and-open obligation share is 18.8 percentage points higher, delivery-order obligation share is 18.0 percentage points higher, and median positive award obligations are 102.5% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 76.7% | 58.5% | +18.2 pts |
| Reported full-and-open obligation share | 28.5% | 9.7% | +18.8 pts |
| Delivery-order obligation share | 45.3% | 27.4% | +18.0 pts |
| Median positive award obligations | $73K | $36K | +102.5% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Defense (DOD)
- Department of Health and Human Services (HHS)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 346 | $61.7M | 45.3% |
| BPA Call(A) | 219 | $42.6M | 31.3% |
| Purchase Order(B) | 138 | $28.8M | 21.2% |
| Definitive Contract(D) | 10 | $2.9M | 2.1% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 267 | $51.8M | 38.1% |
| BPA(E) | 219 | $42.6M | 31.3% |
| FSS(C) | 79 | $9.9M | 7.3% |
| Not reported | 148 | $31.7M | 23.3% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 469 | $93.9M | 69.1% |
| Multiple Award(M) | 96 | $10.3M | 7.6% |
| Not reported | 148 | $31.7M | 23.3% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Simplified Acquisition(SP1) | 303 | $53.8M | 39.6% |
| Only One Source(SSS) | 160 | $43.1M | 31.7% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 220 | $29.9M | 22.0% |
| Negotiated Proposal/Quote(NP) | 30 | $9.2M | 6.8% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not Competed(C) | 157 | $42.6M | 31.3% |
| Full And Open Competition(A) | 246 | $38.8M | 28.5% |
| Competed Under SAP(F) | 198 | $30.0M | 22.0% |
| Not Competed Under SAP(G) | 107 | $23.9M | 17.6% |
| Not Available For Competition(B) | 3 | $473K | 0.35% |
| Full And Open Competition After Exclusion Of Sources(D) | 2 | $325K | 0.24% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Fair Opportunity Given(FAIR) | 126 | $15.1M | 11.1% |
| Only One Source - Other(ONE) | 84 | $14.3M | 10.5% |
| Other Statutory Authority(OSA) | 3 | $340K | 0.25% |
| Follow-On Action Following Competitive Initial Action(FOO) | 3 | $147K | 0.11% |
| Competitive Set Aside(CSA) | 3 | $88K | 0.060% |
| Sole Source(SS) | 1 | $38K | 0.030% |
| Not reported | 493 | $106.1M | 78.0% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 134 | $32.3M | 23.7% |
| SAP Non-Competition (FAR 13)(SP2) | 89 | $18.2M | 13.3% |
| Urgency (FAR 6.302-2)(URG) | 11 | $9.3M | 6.8% |
| Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH) | 21 | $6.2M | 4.6% |
| Brand Name Description (FAR 6.302-1(C))(BND) | 7 | $706K | 0.52% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 3 | $275K | 0.20% |
| Other reported values | 2 | $40K | 0.029% |
| Not reported | 446 | $69.1M | 50.8% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 713 | $136.0M | 100.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| In Vitro Diagnostic Substances, Reagents, Test Kits And Sets(6550) | 458 | $90.6M | 66.6% |
| Laboratory Equipment And Supplies(6640) | 130 | $24.4M | 18.0% |
| Reference Laboratory Testing(Q301) | 28 | $11.3M | 8.3% |
| Medical And Surgical Instruments, Equipment, And Supplies(6515) | 40 | $5.6M | 4.1% |
| Chemical Analysis Instruments(6630) | 18 | $2.6M | 1.9% |
| Drugs And Biologicals(6505) | 9 | $402K | 0.30% |
| Other reported values | 30 | $1.1M | 0.78% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 713 | $136.0M | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 262-Network Contract Office 22 (36c262)(36C262) | 103 | $29.4M | 21.6% |
| 257-Network Contract Office 17 (36c257)(36C257) | 63 | $13.4M | 9.9% |
| 248-Network Contract Office 8 (36c248)(36C248) | 29 | $12.6M | 9.3% |
| 246-Network Contracting Office 6 (36c246)(36C246) | 73 | $10.7M | 7.9% |
| 261-Network Contract Office 21 (36c261)(36C261) | 23 | $7.4M | 5.4% |
| 249-Network Contract Office 9 (36c249)(36C249) | 34 | $7.3M | 5.4% |
| Other reported values | 388 | $55.1M | 40.5% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36C24825D0014(3600) | 7 | $6.2M | 4.5% |
| 36C24626D0001(3600) | 15 | $4.5M | 3.3% |
| 36F79724D0020(3600) | 13 | $3.8M | 2.8% |
| 36C25223D0075(3600) | 8 | $3.1M | 2.3% |
| 36C26225A0004(3600) | 2 | $2.7M | 2.0% |
| 36C25225A0002(3600) | 8 | $2.6M | 1.9% |
| 36C24123A0017(3600) | 1 | $2.4M | 1.7% |
| 36C24625A0011(3600) | 9 | $2.3M | 1.7% |
| Other reported values | 502 | $76.9M | 56.5% |
| Not reported | 148 | $31.7M | 23.3% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 332 reported · 381 not reported
- Positive award obligations
- $73K median
- $29K–$210K middle 50%
- Reported performance period
- 364 days (~12 months) median
- 712 reported · 1 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 11 of 77prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 26.3%of positive obligations in the last 12 months
- Leading four prime contractors
- 68.6%of positive obligations in the last 12 months
- Leading eight prime contractors
- 77.0%of positive obligations in the last 12 months
Based on $108.6M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$28.6M
26.3%
Dollar movement
+$1.5M
vs. prior 12 months
Last 12mo awards
188 awards
244 actions
Historical and award details for BIOMERIEUX INC
- Obligations: prior → latest
- $27.1M → $28.6M
- +5.5%
- Share: prior → latest
- 22.6% → 26.3%
- +3.7 percentage points
- All-period obligations
- $74.0M
- 9.6% of all-period positive obligations · 372 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 17, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 26 35 Not reported 162 125 Reported small business 2 5 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$24.3M
22.4%
Dollar movement
−$7.1M
vs. prior 12 months
Last 12mo awards
114 awards
191 actions
Historical and award details for CEPHEID
- Obligations: prior → latest
- $31.4M → $24.3M
- −22.6%
- Share: prior → latest
- 26.2% → 22.4%
- −3.8 percentage points
- All-period obligations
- $283.9M
- 36.6% of all-period positive obligations · 344 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 8, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 25 25 Not reported 89 100 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$13.6M
12.5%
Dollar movement
+$3.4M
vs. prior 12 months
Last 12mo awards
146 awards
191 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- $10.2M → $13.6M
- +33.4%
- Share: prior → latest
- 8.5% → 12.5%
- +4.0 percentage points
- All-period obligations
- $51.9M
- 6.7% of all-period positive obligations · 439 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 45 45 Not reported 101 111 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$8.0M
7.4%
Dollar movement
+$8.0M
vs. prior 12 months
Last 12mo awards
8 awards
16 actions
Historical and award details for QUEST DIAGNOSTICS INCORPORATED
- Obligations: prior → latest
- $0 → $8.0M
- Not comparable
- Share: prior → latest
- 0% → 7.4%
- +7.4 percentage points
- All-period obligations
- $8.1M
- 1.1% of all-period positive obligations · 9 awards
- Recorded activity
- Since Feb 1, 2023
- through Mar 27, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 8 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$3.7M
3.4%
Dollar movement
+$1.0M
vs. prior 12 months
Last 12mo awards
48 awards
81 actions
Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
- Obligations: prior → latest
- $2.7M → $3.7M
- +38.2%
- Share: prior → latest
- 2.3% → 3.4%
- +1.2 percentage points
- All-period obligations
- $13.7M
- 1.8% of all-period positive obligations · 128 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 10 Not reported 35 36 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.9M
1.7%
Dollar movement
−$923K
vs. prior 12 months
Last 12mo awards
44 awards
54 actions
Historical and award details for ABBOTT LABORATORIES INC.
- Obligations: prior → latest
- $2.8M → $1.9M
- −32.8%
- Share: prior → latest
- 2.4% → 1.7%
- −0.6 percentage points
- All-period obligations
- $8.5M
- 1.1% of all-period positive obligations · 162 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 3 Not reported 40 59 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$1.9M
1.7%
Dollar movement
+$365K
vs. prior 12 months
Last 12mo awards
14 awards
18 actions
Historical and award details for BECTON, DICKINSON AND COMPANY
- Obligations: prior → latest
- $1.5M → $1.9M
- +23.9%
- Share: prior → latest
- 1.3% → 1.7%
- +0.5 percentage points
- All-period obligations
- $4.4M
- 0.56% of all-period positive obligations · 43 awards
- Recorded activity
- Since Oct 1, 2021
- through May 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 9 Not reported 4 3 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$1.7M
1.5%
Dollar movement
−$442K
vs. prior 12 months
Last 12mo awards
3 awards
3 actions
Historical and award details for ABBOTT LABORATORIES INC.
- Obligations: prior → latest
- $2.1M → $1.7M
- −20.9%
- Share: prior → latest
- 1.8% → 1.5%
- −0.2 percentage points
- All-period obligations
- $335K
- 0.040% of all-period positive obligations · 28 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 3 4 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.5M
1.4%
Dollar movement
−$13K
vs. prior 12 months
Last 12mo awards
82 awards
125 actions
Historical and award details for WERFEN USA LLC
- Obligations: prior → latest
- $1.5M → $1.5M
- −0.9%
- Share: prior → latest
- 1.3% → 1.4%
- +0.1 percentage points
- All-period obligations
- $4.6M
- 0.59% of all-period positive obligations · 116 awards
- Recorded activity
- Since Oct 27, 2021
- through Jul 25, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 5 5 Not reported 77 49 Reported small business 18 13 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$1.4M
1.3%
Dollar movement
+$654K
vs. prior 12 months
Last 12mo awards
23 awards
30 actions
Historical and award details for BECKMAN COULTER, INC
- Obligations: prior → latest
- $739K → $1.4M
- +88.6%
- Share: prior → latest
- 0.62% → 1.3%
- +0.7 percentage points
- All-period obligations
- $7.4M
- 0.95% of all-period positive obligations · 82 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 13, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 16 22 Not reported 7 8 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$1.4M
1.3%
Dollar movement
+$118K
vs. prior 12 months
Last 12mo awards
16 awards
20 actions
Historical and award details for GOVERNMENT SCIENTIFIC SOURCE INC
- Obligations: prior → latest
- $1.3M → $1.4M
- +9.3%
- Share: prior → latest
- 1.1% → 1.3%
- +0.2 percentage points
- All-period obligations
- $6.3M
- 0.82% of all-period positive obligations · 70 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 9 6 Not reported 7 7 Reported small business 16 13 All-period set-aside types
- 5 · Total small business
- 1 · Veteran set-aside
- #12
Last 12mo obligations
$1.3M
1.2%
Dollar movement
−$164K
vs. prior 12 months
Last 12mo awards
11 awards
14 actions
Historical and award details for QIAGEN, LLC
- Obligations: prior → latest
- $1.5M → $1.3M
- −10.9%
- Share: prior → latest
- 1.3% → 1.2%
- 0.0 percentage points
- All-period obligations
- $4.8M
- 0.62% of all-period positive obligations · 33 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 13, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 10 10 Not reported 1 2 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$1.3M
1.2%
Dollar movement
+$354K
vs. prior 12 months
Last 12mo awards
15 awards
21 actions
Historical and award details for BINDING SITE, INC., THE
- Obligations: prior → latest
- $977K → $1.3M
- +36.2%
- Share: prior → latest
- 0.82% → 1.2%
- +0.4 percentage points
- All-period obligations
- $5.1M
- 0.66% of all-period positive obligations · 34 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 25, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 1 Reported no set-aside 10 8 Not reported 5 6 Reported small business 14 14 All-period set-aside types
- 1 · Total small business
- #14
Last 12mo obligations
$1.2M
1.1%
Dollar movement
+$352K
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for ONE LAMBDA, INC.
- Obligations: prior → latest
- $847K → $1.2M
- +41.5%
- Share: prior → latest
- 0.71% → 1.1%
- +0.4 percentage points
- All-period obligations
- $3.2M
- 0.41% of all-period positive obligations · 7 awards
- Recorded activity
- Since Mar 2, 2022
- through May 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$1.1M
0.99%
Dollar movement
−$559K
vs. prior 12 months
Last 12mo awards
31 awards
39 actions
Historical and award details for ORTHO-CLINICAL DIAGNOSTICS, INC
- Obligations: prior → latest
- $1.6M → $1.1M
- −34.2%
- Share: prior → latest
- 1.4% → 0.99%
- −0.4 percentage points
- All-period obligations
- $5.6M
- 0.72% of all-period positive obligations · 66 awards
- Recorded activity
- Since Oct 1, 2021
- through Jun 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 13 13 Not reported 18 15 Reported small business 0 0 All-period set-aside types
None reported.
Award activity for In-Vitro Diagnostic Substance Manufacturing at the Department of Veterans Affairs
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
−$1.4M
ABBOTT MOLECULAR INC.
DEPT OF VETERANS AFFAIRS
DE-OBLIGATION OF EXCESS FUNDS
Why it stands out
This award recorded a material contraction.
The action removed $1.4M. A deobligation does not by itself show lower requirement demand.
- Award net obligations
- $815K
- Share of 12-month positive obligations
- 1.3%
Supporting data
- Prime contractor
- 0% share
- −2.3 percentage points · $3.4M net decline; action accounted for 40.1%
- Funding office
- 0% attributed share
- −1.8 percentage points · $2.4M net decline; action accounted for 57.1%
This action
+$2.0M
CEPHEID
644-PHOENIX (00644)
COVID REAGENTS
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 1.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $7.1M overall.
- Award net obligations
- $2.0M
- Share of 12-month positive obligations
- 1.8%
Supporting data
- Prime contractor
- #2 · 22.4% share
- $7.1M net decline despite this positive action
- Funding office
- #3 · 5.7% attributed share
- up 13 ranks · +3.9 percentage points · $4.2M net increase; action accounted for 47.0%
This action
+$1.1M
CEPHEID
261-NETWORK CONTRACT OFFICE 21 (36C261)
CEPHEID REAGENTS DO
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 1.0% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $7.1M overall.
- Award net obligations
- $1.1M
- Share of 12-month positive obligations
- 1.0%
Supporting data
- Prime contractor
- #2 · 22.4% share
- $7.1M net decline despite this positive action
- Funding office
- #2 · 5.9% attributed share
- up 3 ranks · +2.5 percentage points · $2.4M net increase; action accounted for 46.3%
This action
+$2.3M
BIOMERIEUX INC
600-VA LONG BEACH HLTCAR SYS(00600)
POLYMERASE CHAIN REACTION
Why it stands out
The contractor and funding office both climbed their market rankings.
Both rank changes are shown in the supporting movement data.
- Award net obligations
- $2.3M
- Share of 12-month positive obligations
- 2.1%
This action
−$621K
LEICA MICROSYSTEMS INC.
691-VA GREATER LA HLTHCR SYS(00691)
VISN IHC/ISH REAGENTS
Why it stands out
This award recorded a material contraction.
The action removed $621K. A deobligation does not by itself show lower requirement demand.
- Award net obligations
- $552K
- Share of 12-month positive obligations
- 0.57%
Supporting data
- Prime contractor
- #37 · 0.21% share
- down 28 ranks · −1.4 percentage points · $1.7M net decline; action accounted for 36.9%
This action
+$1.9M
ABBOTT LABORATORIES INC.
675-ORLANDO (00675)(36C675)
AUTOMATED CHEMISTRY LABORATORY COST PER TEST
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 1.8% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $442K overall.
- Award net obligations
- $1.9M
- Share of 12-month positive obligations
- 1.8%
Supporting data
- Prime contractor
- #8 · 1.5% share
- $442K net decline despite this positive action
- Funding office
- #10 · 2.4% attributed share
- $508K net decline despite this positive action
View recent award activity by date (10)
- Action−$48Award net obligations$207K
- Action−$219KAward net obligations$2.1M
- Action−$114KAward net obligations$75K
- Action+$38KAward net obligations$38K
- Action−$18KAward net obligations$2.3M
- Action−$3KAward net obligations$116K
- Action+$1KAward net obligations$89K
- Action+$125KAward net obligations$125K
- Action−$55KAward net obligations$12K
- Action−$594KAward net obligations$235K
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology